Search for: "BRISTOL-MYERS SQUIBB" Results 241 - 260 of 863
Sort by Relevance | Sort by Date
RSS Subscribe: 20 results | 100 results
20 Jun 2017, 4:57 am by Walter Olson
My new Cato post applauds the Supreme Court for its 8-1 decision yesterday in Bristol-Myers Squibb v. [read post]
20 Jun 2017, 4:29 am by Edith Roberts
And in Bristol-Myers Squibb Co. v. [read post]
19 Jun 2017, 1:54 pm by Cassandra Burke Robertson
Following up on Howard’s and Stephen’s posts about Bristol-Myers, I think the best thing that can be said about the case is that it creates work for more lawyers in more cases. [read post]
19 Jun 2017, 1:33 pm by Andrew Hamm
.: Ronald Mann analyzed the court’s opinion in Bristol-Myers Squibb Co. v. [read post]
19 Jun 2017, 12:47 pm by Mark Walsh
Before we can even finish pondering that, Alito is on to his second case, Bristol-Myers Squibb Co. v. [read post]
19 Jun 2017, 11:43 am by Autumn Callan
The US Supreme Court [official website] held [opinion, PDF] on Monday that California courts lack specific jurisdiction to hear the claims brought against Bristol-Myers Squibb Co. [read post]
19 Jun 2017, 8:04 am
Justice Alito delivered the opinion of the Court in Bristol-Myers Squibb Co. v. [read post]
15 Jun 2017, 5:34 am by Joe Patrice
Because mom and pop stores like Bristol-Myers Squibb just can't be bothered to litigate in all the places they sell drugs. [read post]
12 Jun 2017, 7:09 am by Robert Kraft
Reuters reports that Bristol-Myers Squibb has agreed to pay $19.5 million to 43 states and the District of Columbia to settle accusations “that it improperly promoted” Abilify (aripiprazole) “for use in children and elderly patients with dementia and Alzheimer’s disease. [read post]
24 May 2017, 7:38 am by Robert Kraft
Bristol-Myers Squibb and Otsuka began marketing the drug in the US in 2002. [read post]
17 May 2017, 8:38 am by Altman & Altman
Abilify is an antipsychotic medication developed by Otsuka Pharmaceutical and Bristol-Myers Squibb that was intended to treat symptoms from schizophrenia, bipolar disorder, Tourette’s syndrome, autism and depression. [read post]
12 May 2017, 9:05 am by Tom Lamb
On April 6, 2017 the United States Judicial Panel On Multidistrict Litigation (JPML) issued this document, "IN RE: FARXIGA (DAPAGLIFLOZIN) PRODUCTS LIABILITY LITIGATION TRANSFER ORDER -- MDL No. 2776", from which we get the following information: The eighteen actions involve allegations that ingestion of the drug Farxiga may cause a variety of injuries, including diabetic ketoacidosis and kidney damage, and that defendants Bristol-Myers Squibb Co., AstraZeneca… [read post]
10 May 2017, 4:14 am by Edith Roberts
Tyrrell, Bristol-Myers Squibb Co. v. [read post]
29 Apr 2017, 10:08 am by Dr. Shezad Malik
Wrendell Chester, from Texas, recently filed a personal injury and product liability lawsuit, against Bristol-Myers Squibb and AstraZeneca, the manufacturers of the drug. [read post]